Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Study of Staging and Prognostic Significance of Bone Marrow Involvement in Malignant Lymphomas in Northern India: Clinicopathological Study


Affiliations
1 Department of Pathology, Mayo Institute of Medical Sciences, Gadia, Barabanki, Lucknow, Uttar Pradesh, India
2 School of Medical Science & Research, Sharda Hospital, Greater Noida, U.P India, India
     

   Subscribe/Renew Journal


Introduction: Bone marrow is not only a reservoir of stem cells but also provides microenvironment for proliferation and development of precursors and regulate the release of mature cells in to circulation. Bone is commonly involved in metastatic tumors and rank third most common site of metastasis after lung and liver. Metastasis may be present in the bone marrow without any abnormalities recognized in bone scans, radiographic pictures, serum chemistry and hematological parameters and remain the only procedure to diagnose the presence of metastatic tumor.

AIMS: To study the clinical features&characteristics of BM involvement in NHL& HL cases with respect to morphology of infiltration for staging and their prognosis.

Materials and Method: A prospective study was conducted on 38cases who had not received any prior specific treatment (chemotherapy and radiotherapy) for both Hodgkin's and non-Hodgkin's lymphoma from northern India, . Out of 38 cases Hodgkin's lymphoma were 08 cases and non- Hodgkin's lymphoma were 30 cases . All cases were examined clinically and later on Bone marrow aspiration and Bone marrow biopsy was obtained from the posterior superior iliac spine. The biopsies were fixed in 10% buffered formalin solution and decalcified using 10% formal - formic acid for 4 - 6 h followed by routine processing. The serial sections were stained by hematoxylin and eosin and reticulin stains. The smears were air dried and immediately fixed in methanol for one of the Romanowsky stain (We used Leishman stain and May-Grunwald Geimsa stain) for cellularity and morphology1. Serial aspiration and biopsies were done in all cases of Hodgkin's and non-Hodgkin's lymphoma

Observations: The most prominent clinical feature was cervical lymphadenopathy. Patients with advanced disease had systemic features like fever, weight loss and hepatosplenomegaly.

The incidence of marrow involvement in known case of Hodgkin's and non-Hodgkin's lymphoma was 25% and 43.33% respectively. The incidence of bone marrow involvement was found in mixed cellularity and in lymphocyte depletion type of Hodgkin Lymphoma cases and the pattern of involvement of bone marrow was diffuse in all the cases.

The extent of marrow involvement was greatest in Non Hodgkin lymphomas that exhibit a diffuse pattern of infiltration. In thirteen cases (43.33%) of bone marrow involvement, seven cases (53.8%) showed presence of neoplastic cells in both aspiration and biopsy while six cases (46.2%) showed presence of neoplastic cells in bone marrow biopsy.

Serial aspiration and biopsies revealed that both cases (100%) of Hodgkin's lymphoma improved with systemic chemotherapy, while five cases (38.46%) of non-Hodgkin's lymphoma showed clearance of bone marrow by the neoplastic cells on completion of chemotherapy.

Conclusion: In all the cases, which infiltrated to bone marrow, histological grades were same as in the FNAC / Histopathology examination at the time of diagnosis from the primary site.

Bone marrow aspiration and biopsy were performed as complimentary procedures.

But Bone marrow biopsy was found superior to bone marrow aspiration.. It was also helpful in the management strategy of the disease as well as to see the response of the therapy by serial aspiration and biopsies10. It was found that in five cases (38.46%) of non-Hodgkin's lymphoma bone marrow showed clearance of tumor cells after completion of chemotherapy.


Keywords

Bone Marrow Involvement, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
Subscription Login to verify subscription
User
Notifications
Font Size


  • Barbara J. Bain, David M. Clark and Irn A. Lampert (1992): Bone marrow pathology. Blackwell scientific publications. Oxford.
  • Bartl R., Frisch B. Burkhardt R. et al (1984): Lymphoproliferations in the bone marrow: Identification and evolution, classification and staging. J. Clin. Pathol. (37): 233 – 254.
  • Burkhardt R., Frisch B., and Bartl R. (1982): Bone marrow biopsy in hematological disorders. J. Clin. Pathol. (35): 257 – 284.
  • Gupta R., Parikh PM and Advani SH et al (1989): Hodgkin’s disease with bone marrow involvement. Indian J. Cancer. (26): 58 – 66.
  • James E. Bearden, Gary A. Ratkin and Charles A. Coltman (1974): Comparision of diagnostic value of bone marrow biopsy and bone marrow aspiration in neoplastic diseases. J. Clin. Pathol. (27): 738 – 740.
  • James F. Welsh and Charles C. Mackinney (1964): Experiences with aspiration biopsies of the bone marrow in the diagnosis and prognosis of carcinoma of the prostate gland. American J. Clin. Pathol. 41 (5): 509 – 512.
  • James N. Ingle, Douglass C. Tormey, Joan M. Bull and Richard M. Simon (1977): Bone marrow involvement in breast cancer. Effect on response and tolerance to combination chemotherapy. Cancer. (39): 104 – 111.
  • Munker R., Hasenclever D., Brosteanu O., Hiller E. and Diehl V. (1995): Bone marrow involvement in Hodgkin’s disease: An analysis of 135 consecutive cases. J. Clin Oncol. 13: 403 – 409.
  • Ramesh Chopra, Sharmila Kumar, Rajiv Rana and Alex Zachariah (1995): Bone marrow involvement in Hodgkin’s disease: Clinicopathological study of seven cases. Indian J. Pathol. Microbiol. 38 (3): 267 – 271.
  • Robbins L., Stanley, Cortan S. Ramzi and Kumar Vinay (1994): Pathologic basis of disease. W. B. Saunders Company. Philadelphia.
  • Robert W. Mckenna and Jose A. Hernandez (1988): Bone marrow in malignant lymphoma. Hematology/Oncology clinics in North America. 2 (4): 617 – 635.
  • Sangeeta desai and Nirmal Jambhekar (1995): Clinicopathological evaluation of metastatic carcinoma of bone: A restrospective analysis of 114 cases over ten years. Indian J. Pathol Microbiol. (38): 49 – 54.
  • Stephen E. Jones, Saul A. Rosenberg and Henry S. Kaplan (1972): Non Hodgkin’s lymphoma. 1- Bone marrow involvement. Cancer. (5): 954 - 960.

Abstract Views: 355

PDF Views: 0




  • Study of Staging and Prognostic Significance of Bone Marrow Involvement in Malignant Lymphomas in Northern India: Clinicopathological Study

Abstract Views: 355  |  PDF Views: 0

Authors

Prem K Garg
Department of Pathology, Mayo Institute of Medical Sciences, Gadia, Barabanki, Lucknow, Uttar Pradesh, India
A Deshmukh
School of Medical Science & Research, Sharda Hospital, Greater Noida, U.P India, India
Geeta Deshmukh
School of Medical Science & Research, Sharda Hospital, Greater Noida, U.P India, India

Abstract


Introduction: Bone marrow is not only a reservoir of stem cells but also provides microenvironment for proliferation and development of precursors and regulate the release of mature cells in to circulation. Bone is commonly involved in metastatic tumors and rank third most common site of metastasis after lung and liver. Metastasis may be present in the bone marrow without any abnormalities recognized in bone scans, radiographic pictures, serum chemistry and hematological parameters and remain the only procedure to diagnose the presence of metastatic tumor.

AIMS: To study the clinical features&characteristics of BM involvement in NHL& HL cases with respect to morphology of infiltration for staging and their prognosis.

Materials and Method: A prospective study was conducted on 38cases who had not received any prior specific treatment (chemotherapy and radiotherapy) for both Hodgkin's and non-Hodgkin's lymphoma from northern India, . Out of 38 cases Hodgkin's lymphoma were 08 cases and non- Hodgkin's lymphoma were 30 cases . All cases were examined clinically and later on Bone marrow aspiration and Bone marrow biopsy was obtained from the posterior superior iliac spine. The biopsies were fixed in 10% buffered formalin solution and decalcified using 10% formal - formic acid for 4 - 6 h followed by routine processing. The serial sections were stained by hematoxylin and eosin and reticulin stains. The smears were air dried and immediately fixed in methanol for one of the Romanowsky stain (We used Leishman stain and May-Grunwald Geimsa stain) for cellularity and morphology1. Serial aspiration and biopsies were done in all cases of Hodgkin's and non-Hodgkin's lymphoma

Observations: The most prominent clinical feature was cervical lymphadenopathy. Patients with advanced disease had systemic features like fever, weight loss and hepatosplenomegaly.

The incidence of marrow involvement in known case of Hodgkin's and non-Hodgkin's lymphoma was 25% and 43.33% respectively. The incidence of bone marrow involvement was found in mixed cellularity and in lymphocyte depletion type of Hodgkin Lymphoma cases and the pattern of involvement of bone marrow was diffuse in all the cases.

The extent of marrow involvement was greatest in Non Hodgkin lymphomas that exhibit a diffuse pattern of infiltration. In thirteen cases (43.33%) of bone marrow involvement, seven cases (53.8%) showed presence of neoplastic cells in both aspiration and biopsy while six cases (46.2%) showed presence of neoplastic cells in bone marrow biopsy.

Serial aspiration and biopsies revealed that both cases (100%) of Hodgkin's lymphoma improved with systemic chemotherapy, while five cases (38.46%) of non-Hodgkin's lymphoma showed clearance of bone marrow by the neoplastic cells on completion of chemotherapy.

Conclusion: In all the cases, which infiltrated to bone marrow, histological grades were same as in the FNAC / Histopathology examination at the time of diagnosis from the primary site.

Bone marrow aspiration and biopsy were performed as complimentary procedures.

But Bone marrow biopsy was found superior to bone marrow aspiration.. It was also helpful in the management strategy of the disease as well as to see the response of the therapy by serial aspiration and biopsies10. It was found that in five cases (38.46%) of non-Hodgkin's lymphoma bone marrow showed clearance of tumor cells after completion of chemotherapy.


Keywords


Bone Marrow Involvement, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma

References